Literature DB >> 22696745

Management of Legionella in the intensive care setting.

Nicholas John Harris1, Anna Claire Victoria Harris, Michael Spiro.   

Abstract

In August 2009, during the swine flu pandemic, a 55-year-old male presented to the Emergency Department (ED) with shortness-of-breath and chest pain. He had experienced diarrhoea and vomiting during the 3 weeks preceding admission, and so had sought the advice of his General Practitioner (GP) who had prescribed a course of oseltamivir (Tamiflu). Despite this, his symptoms had worsened, and on arrival in the ED he was found to be tachypnoeic, tachycardic, feverish, anuric and in type I respiratory failure with a compensated metabolic acidosis. He subsequently became hypotensive, and so was transferred to the Intensive Care Unit (ICU) for supportive treatment of three organ failures. Investigation revealed that he was suffering from Legionnaires disease. This required a prolonged inpatient stay owing to both disease and treatment related complications.

Entities:  

Mesh:

Year:  2011        PMID: 22696745      PMCID: PMC3094801          DOI: 10.1136/bcr.12.2010.3587

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Can Legionnaires disease be diagnosed by clinical criteria? A critical review.

Authors:  L Mulazimoglu; V L Yu
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

2.  BTS guidelines for the management of community acquired pneumonia in adults: update 2009.

Authors:  W S Lim; S V Baudouin; R C George; A T Hill; C Jamieson; I Le Jeune; J T Macfarlane; R C Read; H J Roberts; M L Levy; M Wani; M A Woodhead
Journal:  Thorax       Date:  2009-10       Impact factor: 9.139

Review 3.  Legionella urinary antigen testing: potential impact on diagnosis and antibiotic therapy.

Authors:  A D Kashuba; C H Ballow
Journal:  Diagn Microbiol Infect Dis       Date:  1996-03       Impact factor: 2.803

4.  Community-acquired pneumonia: the annual cost to the National Health Service in the UK.

Authors:  J F Guest; A Morris
Journal:  Eur Respir J       Date:  1997-07       Impact factor: 16.671

Review 5.  Legionellosis.

Authors:  J E Stout; V L Yu
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

6.  Prognostic factors of severe Legionella pneumonia requiring admission to ICU.

Authors:  M el-Ebiary; X Sarmiento; A Torres; S Nogué; E Mesalles; M Bodí; J Almirall
Journal:  Am J Respir Crit Care Med       Date:  1997-11       Impact factor: 21.405

7.  The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group.

Authors:  M J Tan; J S Tan; R H Hamor; T M File; R F Breiman
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

9.  Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department.

Authors:  David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

Review 10.  The atypical pneumonias: clinical diagnosis and importance.

Authors:  B A Cunha
Journal:  Clin Microbiol Infect       Date:  2006-05       Impact factor: 8.067

View more
  1 in total

1.  Severe Legionella Pneumophila Infection in an Immunocompetent Patient: A Success Story 300 Kilometers Away.

Authors:  Miguel Jacob; Helena C Ramos; Bruno Morgado
Journal:  Cureus       Date:  2016-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.